Akhter Tahmina, Mileti Enrichetta, Kere Maura M, Kolmert Johan, Konradsen Jon R, Hedlin Gunilla, Melén Erik, Daub Carsten O
Department of Biosciences and Nutrition, Karolinska Institutet, 141 83, Stockholm, Sweden.
Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 118 83, Stockholm, Sweden.
Heliyon. 2024 Jul 9;10(14):e34386. doi: 10.1016/j.heliyon.2024.e34386. eCollection 2024 Jul 30.
Children with severe asthma suffer from recurrent symptoms and impaired quality of life despite advanced treatment. Underlying causes of severe asthma are not completely understood, although genetic mechanisms are known to be important.
The aim of this study was to identify gene regulatory enhancers in leukocytes, to describe the role of these enhancers in regulating genes related to severe and mild asthma in children, and to identify known asthma-related SNPs situated in proximity to enhancers.
Gene enhancers were identified and expression of enhancers and genes were measured by Cap Analysis Gene Expression (CAGE) data from peripheral blood leukocytes from children with severe asthma (n = 13), mild asthma (n = 15), and age-matched controls (n = 9).
From a comprehensive set of 8,289 identified enhancers, we further defined a robust sub-set of the high-confidence and most highly expressed 4,738 enhancers. Known single nucleotide polymorphisms, SNPs, related to asthma coincided with enhancers in general as well as with specific enhancer-gene interactions. Blocks of enhancer clusters were associated with genes including TGF-beta, PPAR and IL-11 signaling as well as genes related to vitamin A and D metabolism. A signature of 91 enhancers distinguished between children with severe and mild asthma as well as controls.
Gene regulatory enhancers were identified in leukocytes with potential roles related to severe and mild asthma in children. Enhancers hosting known SNPs give the opportunity to formulate mechanistic hypotheses about the functions of these SNPs.
尽管接受了先进的治疗,但重度哮喘患儿仍会出现反复症状,生活质量受损。虽然已知遗传机制很重要,但重度哮喘的潜在病因尚未完全明确。
本研究的目的是鉴定白细胞中的基因调控增强子,描述这些增强子在调节儿童重度和轻度哮喘相关基因中的作用,并鉴定位于增强子附近的已知哮喘相关单核苷酸多态性(SNP)。
通过对重度哮喘患儿(n = 13)、轻度哮喘患儿(n = 15)和年龄匹配的对照儿童(n = 9)外周血白细胞的帽分析基因表达(CAGE)数据,鉴定基因增强子并测量增强子和基因的表达。
从总共鉴定出的8289个增强子中,我们进一步定义了一个由4738个高可信度且表达水平最高的增强子组成的可靠子集。与哮喘相关的已知单核苷酸多态性(SNP)总体上与增强子以及特定的增强子 - 基因相互作用相吻合。增强子簇块与包括转化生长因子 - β、过氧化物酶体增殖物激活受体和白细胞介素 - 11信号通路相关的基因以及与维生素A和D代谢相关的基因有关。91个增强子的特征区分了重度和轻度哮喘患儿以及对照儿童。
在白细胞中鉴定出了基因调控增强子,其在儿童重度和轻度哮喘中可能发挥潜在作用。含有已知SNP的增强子为阐述这些SNP的功能机制假说提供了机会。